Clinical Trial Update: Pembro+Chemo in Brain Mets [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab plus chemotherapy for brain metastases from lung cancer was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Lung Cancer
• Lung Cancer Metastatic

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: John L. Villano, MD, PhD | Conditions: Lung Cancer, Lung Cancer Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2024-10-21